Haryana FDA conducts major anti-drug raids across Hisar, Karnal, and Kalanwali: Peethaambaran Kunnathoor, Chennai Saturday, February 14, 2026, 08:00 Hrs [IST] In a coordinated eff ...

US FDA acknowledges no filing deficiencies in Biofrontera’s sNDA for Ameluz PDT in superficial basal cell carcinoma: Woburn, Massachusetts Saturday, February 14, 2026, 16:00 Hrs ...

Merck to present data across multiple genitourinary cancers from several approved and investigational medicines at 2026 ASCO GU cancers symposium: Rahway, New Jersey Saturday, Feb ...

Exports of Ayush and herbal products have reported a decline of 7.42% during the first nine months of the fiscal year 2025-26 ...

Sophia Antipolis, France Saturday, February 14, 2026, 17:00 Hrs [IST] ...

PCI asks institutions to submit SIF for 2026-27 by February 27: Our Bureau, New Delhi Saturday, February 14, 2026, 08:00 Hrs ...

LifeScan partners with i-SENS to launch OneTouch brand for continuous glucose monitoring system: Malvern, Pennsylvania Saturday, February 14, 2026, 15:00 Hrs [IST] LifeScan, a glo ...

Dewpoint Therapeutics selects a development candidate for its MYC programme: Boston Saturday, February 14, 2026, 18:00 Hrs [IST] Dewpoint Therapeutics Inc, a biotechnology company ...

Baird Medical drives US market penetration by launching MWA technology at Bakersfield Memorial Hospital: New York Saturday, February 14, 2026, 13:00 Hrs [IST] Baird Medical Invest ...

Novartis announced final results from the phase III ALIGN study supporting a slowing decline in kidney function in adults with IgA nephropathy (IgAN) who were treated with Vanrafia (atrasentan).

WHO prequalifies Biological E’s novel oral polio vaccine type 2, to strengthen global outbreak response: Our Bureau, Mumbai Saturday, February 14, 2026, 09:00 Hrs [IST] The Worl ...

Amgen's Uplizna receives European approval to treat generalized myasthenia gravis: Thousand Oaks, California Saturday, February 14, 2026, 11:00 Hrs [IST] Amgen announced the Europ ...